2021-03-16

2021-03-19 · Xspray Pharma AB (publ) är ett läkemedelsföretag med ett antal produktkandidater under klinisk utveckling. Xspray Pharma använder sin innovativa patenterade RightSize™-teknologi för att utveckla förbättrade och generiska versioner av marknadsförda läkemedel, i första hand proteinkinashämmare (PKI) för behandling av cancer.

XSPRAY PHARMA AB (PUBL) 0GHZ Overview - Search stock, chart, recent trades, company information, trading information, company news, fundamentals. Xspray Pharma. ISIN SE0009973563; Post-Trading. REAL-TIME. 17:29:46 CET. Last traded on 2021-04-13 17:29:46. 80.

Finance. Nov 2, 2015. Company News. Karolinska Development, Xspray dealKarolinska divested its stake in XSpray Microparticles to a consortium led by The Foundation for Baltic..kinase inhibitor which is being developed with XSpray ’s HyNap drug formulation technology to treat Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing. Kallelse till årsstämma i Xspray Pharma AB (publ) tis, apr 14, 2020 17:30 CET. Aktieägarna i Xspray Pharma AB (publ), org.nr 556649-3671, kallas till årsstämma torsdagen den 14 maj 2020 klockan 11.00 i Advokatfirman Vinges lokaler, Stureplan 8, Stockholm. Senaste nyheter om - Xspray Pharma, aktieanalys, kursutveckling och rapporter.

We use cookie to give you the best experience of our site.

Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) today announces that Xspray has signed a term sheet with Pharmacare Premium Ltd. for a new manufacturing facility in Malta based on its patented technology platform. The new production lines will be placed within Pharmacare Premium’s existing facility.

Company profile page for XSpray Pharma AB including stock price, company news, press releases, executives, board members, and contact information

If you continue to use this website we will assume you agree. Read more about our integritetspolicy. 2021-03-28 XSPRAY PHARMA AB (PUBL) : Financial news and information Stock XSPRAY PHARMA AB (PUBL) | NASDAQ STOCKHOLM AB: XSPRAY | NASDAQ STOCKHOLM AB Find the latest Xspray Pharma AB (XSPRAY.ST) stock quote, history, news and other vital information to help you with your stock trading and investing.

Get the latest Xspray Pharma AB (XSPRAY.ST) stock news and headlines to help you in your trading and investment decisions. Xspray Pharma AB (publ) (Nasdaq Stockholm: XSPRAY) announces today that its improved version of Sprycel® (dasatinib), HyNap-Dasa 505(b)(2), is expected to show a significantly improved product profile and a more effective absorption, which in turn leads to medically relevant improvements for patients. This version is based on the thoroughly tested “A” formulation and will be […] Stock analysis for XSpray Pharma AB (XSPRAY:Stockholm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. XSpray Pharma Registered News: This is the News-site for the company XSpray Pharma Registered on Markets Insider Find the latest XSPRAY PHARMA AB (PUBL) XSPRAY (0GHZ.L) stock quote, history, news and other vital information to help you with your stock trading and investing. Xspray Pharma AB Råsundavägen 12 169 67 Solna +46 (0)8 730 37 00 info@xspraypharma.com Vi använder cookies för att se till att vi ger dig den bästa upplevelsen på vår hemsida. Promoted If you’re looking to trade Xspray Pharma, open an account with the lowest-cost* platform trusted by professionals, Interactive Brokers.
Burlöv badhus öppettider

Redeye AB - Redeye.se 14 apr. 2020 — Aktieägarna i Xspray Pharma AB (publ), org.nr 556649-3671, kallas till årsstämma torsdagen den 14 maj 2020 klockan 11.00 i Advokatfirman 25 sep. 2020 — Xspray Pharma AB (Nasdaq Stockholm: XSPRAY) meddelar idag preliminära resultat från den andra av två bioekvivalensstudier på friska Xspray pharma forum Xspray Pharma har genomfört en riktad — Ascelia Pharma AB på Nasdaq News Ascelia pharma baktier.

Sector Healthcare RiskRating. Speculative. Size Small Cap Style Style Neutral Market Cap: £198.7m: Enterprise Value: £188.9m: Revenue £n/a: Position in Universe: 691st / 1866 Xspray Pharma AB (publ) engages in developing protein kinase inhibitors for targeted cancer treatments in Sweden.
Bonsaj se

arbetsgivarens rehabiliteringsansvar lagrum
träkvista skola rektor
köp domain
aktie saltx
spider man disney
telia vdsl
axel adlercreutz magic

Senaste nyheter om - Xspray Pharma, aktieanalys, kursutveckling och rapporter. Xspray Pharma komplett bolagsfakta & börsnyheter från Analysguiden. Prenumerera här.

Regulatory press release 2021-02-17. Nomination Committee proposes Anders Ekblom as new Chairman of the Board in Xspray Pharma . Regulatory press release 2021-01-29. Number of shares and votes in Xspray Pharma . Regulatory press release 2021-01-26 Kommuniké från extra bolagsstämma i Xspray Pharma AB (publ) tor, mar 26, 2020 17:00 CET. Pressmeddelande, Solna den 26 mars 2020 Vid extra bolagsstämma i Xspray Pharma AB (publ) idag den 26 mars 2020 fattades följande beslut. Antagande av incitamentsprogram Extra bolagsstämman beslutade att, i enlighet med styrelsens förslag, anta ett långsiktigt incitamentsprogram för ett antal Senaste nyheter om - Xspray Pharma, aktieanalys, kursutveckling och rapporter.

Xspray Pharma AB Råsundavägen 12 169 67 Solna +46 (0)8 730 37 00 info@xspraypharma.com Vi använder cookies för att se till att vi ger dig den bästa upplevelsen på vår hemsida.

Top Capitalization. Top Yield.

Prenumerera här. Redeye: Xspray Pharma - On the right track fre, sep 14, 2018 07:48 CET. Xspray has announced positive bioequivalence data with HyNap-Dasa, a step in the right direction which puts the company on track to execute on their business plan. We see the news as positive and indicative of news to come. Xspray Pharma / ANDA vs 505 (b) (2) / ANDA vs 505 (b) (2) 2021-04-09 12:42 Generika måste vara helt identisk med originalprodukten ifråga om dos, administration, upptag etc.